Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Liver Transpl. 2022 Jun 16;28(8):1321–1331. doi: 10.1002/lt.26460

Table 2:

Incidence of Major Adverse Cardiac Events (MACE) after Liver Transplant by Cirrhotic Cardiomyopathy (CCM) Definition

Original CCM Definition Revised CCM Definition
Cardiac Events No CCM (N = 48) CCM (N = 162) No CCM (N = 146) CCM (N = 64)
MACE 6 (12%) 38 (23%) 25 (17%) 19 (30%)
Arrhythmia 1 (2%) 18 (11%) 11 (8%) 8 (12%)
Heart Failure 3 (6%) 15 (9%) 10 (7%) 8 (12%)
Cardiac Arrest or Cardiac Death 2 (4%) 14 (9%) 7 (5%) 9 (14%)
All-Cause Mortality 6 (12%) 25 (15%) 19 (13%) 12 (19%)